CSIS Medication Review Solution

Patients with multiple coexisting conditions often face the challenge of drug interactions that can result in harmful Adverse Drug Events (ADEs). Evidence-based guidelines for care are largely focused on single diseases and fail to address the complexities of polypharmacy. The CSIS Medication Review Solution helps prevent hospital admissions by identifying harmful medications, enabling healthcare teams to optimise treatment for patients with multiple conditions.

Comprehensive reviews and real-time alerts

Using the widely recognised StoppStart™ and AGS Beers™ criteria, the CSIS Medication Review Solution automatically reviews each patient’s medical record, considering their full medical history, diagnosis list, and medication regimen. This intelligent technology suggests medication adjustments and identifies potentially omitted drugs, ensuring more accurate, patient-centred care. Clinicians receive real-time alerts at the point of consultation, ensuring timely interventions.

The platform also provides powerful analytics, offering both patient-level and population-level reporting to track medication safety, prescribing practices, and cost-saving opportunities.

Please note all enquiries will be forwarded to the partner and will not be responded to by Enlivio Health (formerly Optum | EMIS).

Key benefits

• Prevent hospital admissions by identifying potentially harmful medications and reducing adverse drug events (ADEs)
• Optimise medication regimens using best practice guidelines for polypharmacy and multi-morbidity patients
• Drive cost savings through improved prescribing and reduced hospital re-admissions